Avid Radiopharmaceuticals

📍 Philadelphia, United States👥 124 employees💰 Last funded May 2007
Pharmaceutical Manufacturing🌐 avidrp.com
Website LinkedIn
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Avid Radiopharmaceuticals?
Avid Radiopharmaceuticals has 2 investors on record on gritt.io.
When did Avid Radiopharmaceuticals last raise funding?
The most recent investment in Avid Radiopharmaceuticals recorded on gritt.io was in May 2007.
What industry is Avid Radiopharmaceuticals in?
Avid Radiopharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Avid Radiopharmaceuticals based?
Avid Radiopharmaceuticals is headquartered in Philadelphia, United States.